» Articles » PMID: 25233487

MHC Class II Restricted Innate-like Double Negative T Cells Contribute to Optimal Primary and Secondary Immunity to Leishmania Major

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2014 Sep 19
PMID 25233487
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Although it is generally believed that CD4(+) T cells play important roles in anti-Leishmania immunity, some studies suggest that they may be dispensable, and that MHC II-restricted CD3(+)CD4(-)CD8(-) (double negative, DN) T cells may be more important in regulating primary anti-Leishmania immunity. In addition, while there are reports of increased numbers of DN T cells in Leishmania-infected patients, dogs and mice, concrete evidence implicating these cells in secondary anti-Leishmania immunity has not yet been documented. Here, we report that DN T cells extensively proliferate and produce effector cytokines (IFN-γ, TNF and IL-17) and granzyme B (GrzB) in the draining lymph nodes and spleens of mice following primary and secondary L. major infections. DN T cells from healed mice display functional characteristics of protective anti-Leishmania memory-like cells: rapid and extensive proliferation and effector cytokines production following L. major challenge in vitro and in vivo. DN T cells express predominantly (> 95%) alpha-beta T cell receptor (αβ TCR), are Leishmania-specific, restricted mostly by MHC class II molecules and display transcriptional profile of innate-like genes. Using in vivo depletion and adoptive transfer studies, we show that DN T cells contribute to optimal primary and secondary anti-Leishmania immunity in mice. These results directly identify DN T cells as important players in effective and protective primary and secondary anti-L. major immunity in experimental cutaneous leishmaniasis.

Citing Articles

Causal relationship between inflammatory proteins, immune cells, and gout: a Mendelian randomization study.

Lai R, Deng X, Lv X, Zhong Y Sci Rep. 2024; 14(1):30070.

PMID: 39627303 PMC: 11615377. DOI: 10.1038/s41598-024-80138-2.


T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.

Macchia I, La Sorsa V, Ciervo A, Ruspantini I, Negri D, Borghi M Biomolecules. 2024; 14(10).

PMID: 39456150 PMC: 11505848. DOI: 10.3390/biom14101217.


Identification of immune traits associated with neurodevelopmental disorders by two-sample Mendelian randomization analysis.

Chen J, Han Z, Wang Z, Chen L, Wang S, Yao W BMC Psychiatry. 2024; 24(1):728.

PMID: 39448971 PMC: 11515564. DOI: 10.1186/s12888-024-06148-6.


A chronic mouse lung infection modeling the pathophysiology and inflammation of human cystic fibrosis.

Vaillancourt M, Aguilar D, Fernandes S, Jorth P bioRxiv. 2024; .

PMID: 39416002 PMC: 11482824. DOI: 10.1101/2024.10.07.617039.


IL-33 promotes double negative T cell survival via the NF-κB pathway.

Sun X, Zhang C, Sun F, Li S, Wang Y, Wang T Cell Death Dis. 2023; 14(4):242.

PMID: 37019882 PMC: 10076344. DOI: 10.1038/s41419-023-05766-4.


References
1.
Lezama-Davila C, Gallagher G . CD4+, CD8+ and CD4- CD8- T cell-subsets can confer protection against Leishmania m. mexicana infection. Mem Inst Oswaldo Cruz. 1995; 90(1):51-8. DOI: 10.1590/s0074-02761995000100012. View

2.
Restrepo C, Rallon N, Del Romero J, Rodriguez C, Sempere-Ortells J, de la Vega E . HIV Gag-specific immune response mediated by double negative (CD3(+)CD4(-)CD8(-)) T cells in HIV-exposed seronegative individuals. J Med Virol. 2012; 85(2):200-9. DOI: 10.1002/jmv.23447. View

3.
Reithinger R, Dujardin J, Louzir H, Pirmez C, Alexander B, Brooker S . Cutaneous leishmaniasis. Lancet Infect Dis. 2007; 7(9):581-96. DOI: 10.1016/S1473-3099(07)70209-8. View

4.
Voelkl S, Gary R, Mackensen A . Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells. Eur J Immunol. 2011; 41(3):739-48. DOI: 10.1002/eji.201040982. View

5.
Zaph C, Uzonna J, Beverley S, Scott P . Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med. 2004; 10(10):1104-10. DOI: 10.1038/nm1108. View